About Brett Giroir
Brett Giroir is a chairman & interim CEO at OncoNano Medicine.
Form D filings also name Brett Giroir as an executive officer and director at Altesa BioSciences.
Brett Giroir first appears on SEC filings in 2023.
Experience
This experience comes from Brett Giroir's profile and from SEC filings. For roles taken from filings, the years are when the filings name Brett Giroir in the role, so the role may have started earlier or lasted longer.
RH
Research!America: Discovery. Innovation. Health. Current
Board Member
2026 – Present
OncoNano Medicine, Inc. Current
Chairman & Interim CEO
Chairperson of the Board (2021 – Present)
2021 – Present · Dallas, TX
Develops experimental cancer treatments and drug delivery technology for patients with cancer.
Altesa BioSciences, Inc.
Chief Executive Officer (2022 – 2026)
Director
2022 – 2026 · College Park, GA
Develops an oral antiviral medicine for people with chronic lung disease.
GN
Global Virus Network
Member Board of Directors
2022 – 2025
UH
U.S. Department of Health and Human Services (HHS)
Policy Adviser / Special Government Employee
2018 – 2025
GT
Global Blood Therapeutics
Social Empowerment Council
2021 – 2022
LP
Leavitt Partners
Distinguished Visiting Executive
2021 – 2022
US
U.S. Department of State
US Representative to the World Health Organization Executive Board
2020 – 2021
TH
The White House
White House Coronavirus Task Force
2020 – 2021
FD
FDA
FDA Commissioner (Acting)
2019 – 2020
AL
AlloVir (then ViraCyte, LLC)
Chief Executive Officer
2016 – 2018
BM
Baylor College of Medicine
Adjunct Professor of Pediatrics, Tropical Medicine, and Medical Ethics and Health
2015 – 2018
TC
Texas A&M Health Science Center
Executive VP and CEO, and Professor
2013 – 2015
TS
Texas A&M University System
Vice Chancellor
2008 – 2013
DD
Defense Advanced Research Projects Agency (DARPA)
Director, Defense Sciences Office
2004 – 2008
Key Colleagues at Startups
The people Brett Giroir works with at each company, as listed on that company's latest Form D.
OncoNano Medicine, Inc. · Form D, Oct 8, 2026
Brent Sorrells
Chief Operating Officer
JD
John Dyett
Co-Founder and Managing Director
GJ
Gina Jones
Director
YQ
Yumin Qui
Director
Altesa BioSciences, Inc. · Form D, Feb 23, 2026
John Clerici
President and Chief Operating Officer
NW
Nicholas Williams
Director
Moncef Slaoui
Chair
AD
Andrew Drechsler
Executive officer
Seth Rudnick
Altesa Co-Founder and director
Jon Edwards
Board Member
Ittai Harel
Managing and director